The US contributes significantly to the growth of the defibrillator market in North America. The U.S. is expected to contribute significantly due to rise in adoption of innovative defibrillator technology. Hospitals and clinics in the U.S. are equipped with latest defibrillation devices and applications, which are essential to perform critical cardiac arrest. Cleveland Clinic, Mayo Clinic, New York-Presbyterian University Hospital of Columbia, and Cornell are some of the key hospitals contributing to the growth of defibrillator market.
Further, there are organizations such as Oklahoma Health Care Authority (OHCA) and Indiana Health Care Association (IHCA) for public health in the US. Each year, over 350,000 emergency medical services-assessed out-of-hospital cardiac arrests occur in the US.CARES, a non-profit organization, designed to help emergency medical services (EMS) agencies, evaluates and improves their performance in cardiac arrest response, and monitors and reports data on patients who received EMS treatment (CPR and/or defibrillation). As a result, the total incidence reported by each database ranges from approximately 180,000 to 395,000 cases.
According to Center for Disease Control & Prevention (CDC), the U.S. national healthcare expenditure was around $3 trillion in 2014. The U.S. has the highest healthcare spending across the globe. In the U.S., the per capita healthcare expenditure per person in 2014 was around $9,523. The North American market has the highest contribution from the US due to significant development in defibrillator market and presence of world’s finest hospitals. The U.S. has a considerable contribution in defibrillator market, however rise in medical tourism and high cost of implantable defibrillation may affect the growth of defibrillator market in the U.S.
Research Methodology
The market study of the US Defibrillators market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis.The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. US Defibrillators Market Research and Analysis by Type
2. US Defibrillators Market Research and Analysis by End-users
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. US Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. US Defibrillators Market by End-Users
5.2.1. Hospitals
5.2.2. Ambulatory Services and Others
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Biotronik SE & Co. KG
6.3. Cintas Corp.
6.4. Defibtech, LLC
6.5. General Electric Co.
6.6. Koninklijke Philips N.V.
6.7. LivaNova PLC
6.8. Medtronic PLC
6.9. Mindray Medical International Co. Ltd.
6.10. Nihon Kohden Corp.
6.11. Stryker Corp.
6.12. ZOLL Medical Corp. (an Asahi Kasei Group company)
1. US DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. US DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2025 ($ MILLION)
1. US DEFIBRILLATORS MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. US DEFIBRILLATORS MARKET SHARE BY END-USERS, 2018 VS 2025 (%)